CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 11,006 shares at $1.32 ($14,528)
- 4 Open-market buy Chief Financial Officer bought 45,237 shares at an average $1.32 ($59,716)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 33,784 shares at $1.50 ($50,676)
- 4 Open-market sale Chief Scientific Officer sold 18,849 shares at $2.06 ($38,829)
- 4 Open-market sale General Counsel and Secretary sold 9,833 shares at $2.06 ($20,256)
- 4 Exercise or conversion Chief Financial Officer acquired 47,728 shares (option exercise)
- 4 Exercise or conversion VP & Corporate Controller acquired 6,061 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 14 · 269 filings